Final Fantasy 7: Rebirth Sales Are Fine, but It's No Dragon's Dogma 2
It's natural that everyone's been a little antsy about Final Fantasy 7: Rebirth lately. For weeks, analysts and fans have been discussing the game's potential underperformance compared to its predecessor, Remake, amid worries this might impact the future of the 7 Remake trilogy. Today, we got a little more data on what's really going on here - though the jury is still out on how publisher Square Enix is looking at the numbers.
Today, Circana published its monthly video game consumer spending report for March, which offers insight on the U.S. market calculated by dollar sales. One of the more notable games in the rankings this month was Final Fantasy 7: Rebirth, which reports have suggested isn't selling as well as Square Enix would like despite critical acclaim. Without actual sales figures, it's difficult to tell, and our analysis a few weeks ago indicated that it's doing....eh, fine, just not gangbusters.
Today's Circana report paints a similarly perplexing picture. Rebirth is still the fourth best-selling game this year so far, but it's also the 14th best-selling Final Fantasy game ever - well behind Final Fantasy 15 in first place, Final Fantasy 7: Remake in second, and the original Final Fantasy 7 in third place. Granted, it's only had two months on the market on a single platform while the others have had multiple years on multiple platforms, so we can give it some grace there.
We asked Circana analyst Mat Piscatella for a bit more context on what's going on with Rebirth's U.S. sales. He told us that Rebirth sales in the U.S. are down a double-digit percentage when compared to both Remake and Final Fantasy 16 over the same time in market - so that's not great. But he also noted, again, that Remake launched "at basically the best time to launch a video game in history, and on a different installed base, with all that built up anticipation." And he called the game's performance "not amazing, but also nowhere near terrible." Which is roughly what other experts have
Read more on ign.com
